FDA Approves Aducanumab — A Controversial Dru...

When producer Berly McCoy was out on her local frozen lake, she saw something she'd never seen before. There were dark spidery, star-shaped patterns in the ice and they freaked her out. So, we called an expert to find out more about them. In today’s episode, geophysicist Victor T ...  Show more

In 1999 hundreds of gray whales washed up along the west coast of North America. More in 2000. They lost an estimated 25% of their population. But then the whale population recovered and people moved on. Until it happened again in 2019. And 2020, and 2021. It’s still happening to ...  Show more

After decades without progress, this June a new treatment was approved by the US Food and Drugs Administration - Biogen's Aduhelm. Ivana Davidovic looks into why this process has been so controversial that is now under investigation by a federal watchdog.Aaron Kesselheim, a Harva ...  Show more

When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.

But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cogni ...

Drug policy feels very unsettled right now. The war on drugs was a failure. But so far, the war on the war on drugs hasn’t entirely been a success, either.

Take Oregon. In 2020, it became the first state in the nation to decriminalize hard drugs. It was a paradigm shift ...

For many years, pharmaceutical companies have tried and failed to find a treatment to slow symptoms of ALS–the debilitating, fatal illness also known as Lou Gehrig’s Disease. A potentially promising new drug from Biogen may offer some relief to those afflicted with an uncommon an ...  Show more